Towa Pharmaceutical Co., Ltd. (TYO:4553)

Japan · Delayed Price · Currency is JPY

3,950.00

+90.00 (2.33%)

May 29, 2026, 3:30 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Overseas		53.87B	49.32B	53.49B	38.94B	-
Overseas Growth		9.21%	-7.78%	37.36%	-	-
Unallocated Adjustment Amount		-374.00M	-105.00M	-166.00M	-	-
Domestic		206.10B	178.72B	155.54B	126.68B	-
Domestic Growth		15.32%	14.90%	22.78%	-	-
Pharmaceuticals Business		-	-	-	-	154.90B
Pharmaceuticals Business Growth		-	-	-	-	40.33%
Total		259.59B	227.93B	208.86B	165.61B	154.90B
Total Growth		13.89%	9.13%	26.11%	6.92%	40.33%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Japan		195.44B	169.23B	146.96B	126.60B	118.69B
Japan Growth		15.49%	15.15%	16.08%	6.67%	7.52%
Abroad		64.15B	58.71B	61.90B	39.01B	36.21B
Abroad Growth		9.27%	-5.16%	58.68%	7.72%	-
Total		259.59B	227.93B	208.86B	165.62B	154.90B
Total Growth		13.89%	9.13%	26.11%	6.92%	40.33%

Source: S&P Global Market Intelligence.